Hedera-22 is a Biotechnology company that specializes in the innovative products based on the use of new natural molecules.
Hedera-22 has raised $2.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2024.
Hedera-22's investors include Meusinvest (Noshaq), Aravis Ventures, Gesval, K & E.
Hedera-22 is headquartered in Liège, Belgium.
Hedera-22 is a Biotechnology company that specializes in the innovative products based on the use of new natural molecules.
Hedera-22 is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hedera-22 — Funding & Investors." VCBacked, August 14, 2024, https://www.vcbacked.co/company/hedera-22. Accessed August 14, 2026.
VCBacked. (2024). Hedera-22 — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/hedera-22
{{cite web |title=Hedera-22 — Funding & Investors |url=https://www.vcbacked.co/company/hedera-22 |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated